High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

Abstract

INTRODUCTION:

Epidermal growth factor receptor (EGFR) mutation has been known to be associated with adenocarcinoma with bronchioloalveolar carcinoma (BAC; lepidic) feature. This study was aimed to characterize the frequency of EGFR mutations and their association with histologic subtypes in Korean nonsmall cell lung cancer (NSCLC) patients.

METHODS:

Three hundred eighty-two (88 biopsies and 294 resections) NSCLC patients were investigated for EGFR mutations (exons 18-21) by polymerase chain reaction and direct sequencing method. For the resected adenocarcinoma specimens, histologic subtypes were classified according to both 2004 World Health Organization classification and 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. The results were correlated with EGFR mutation and clinicopathologic features.

RESULTS:

EGFR mutations were detected in 196 of 382 NSCLCs (51.3%) and were more frequent in women than in men (65.7% versus 34.3%, p < 0.001) and in nonsmokers than in smokers (63.4% versus 32.0%, p < 0.001). Regarding histologic subtypes of adenocarcinoma, mixed acinar and BAC pattern showed the most frequent EGFR mutation (67.6%), followed by mixed papillary and acinar (65.2%), mixed solid and acinar (38.2%), micropapillary and acinar (30.4%), and acinar and mucinous BAC (13.3%). In addition, EGFR mutations were more frequently observed in tumors with BAC or papillary components than those with mucinous BAC or solid components. Identical EGFR mutations were detected in a single tumor showing mixed histological features. EGFR protein expression was seen more frequently in tumors with EGFR mutations than those without EGFR mutations (75.3% versus 24.7%, p=0.003). EGFR mutations were significantly more common in tumors with thyroid transcription factor-1 (TTF-1) expression than those without TTF-1 (p < 0.001), and almost all (92.7%) mutated adenocarcinomas were TTF-1 positive.

CONCLUSIONS:

The incidence of EGFR mutations is variable according to histologic subtypes, gender, and smoking history. The mixed acinar and BAC and papillary and acinar subtypes, the presence of BAC (lepidic) or papillary components, EGFR, and TTF-1 protein expression can predict higher EGFR mutation in lung adenocarcinoma. However, intratumoral heterogeneity of EGFR mutation was not found. In addition, relatively high incidence of EGFR mutations in Korean men who smoked with adenocarcinoma histology suggests that these patients should not be left behind EGFR mutation test.

• Authors: Ping-Li Sun, Hyesil Seol, Hyun Ju Lee, Seol Bong Yoo, Hyojin Kim, Xianhua Xu, Sanghoon Jheon, Choon-Taek Lee, Jong-Suk Lee, Jin-Haeng Chung
• Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (J Thorac Oncol) Vol. 7 Issue 2 Pg. 323-30 (Feb 2012) ISSN: 1556-1380 [Electronic] United States
• PMID: 22237264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• DNA, Neoplasm
• DNA-Binding Proteins
• TTF1 protein, human
• Transcription Factors
• EGFR protein, human
• ErbB Receptors

Topics

• Adenocarcinoma (epidemiology, genetics, metabolism, pathology)
• Adenocarcinoma, Bronchiolo-Alveolar (epidemiology, genetics, metabolism, pathology)
• Adult
• Aged
• Aged, 80 and over
• Carcinoma, Non-Small-Cell Lung (epidemiology, genetics, metabolism, pathology)
• DNA, Neoplasm (genetics)
• DNA-Binding Proteins (metabolism)
• ErbB Receptors (genetics, metabolism)
• Female
• Humans
• Immunoenzyme Techniques
• Incidence
• Lung Neoplasms (epidemiology, genetics, metabolism, pathology)
• Male
• Middle Aged
• Mutation (genetics)
• Neoplasm Staging
• Polymerase Chain Reaction
• Prognosis
• Smoking (genetics)
• Transcription Factors